combination chemotherapy

Combination chemotherapy means giving several anticancer drugs together instead of one alone. The logic is like attacking a fortress from several directions at once: if defenders can block one assault, they are far less likely to block all of them simultaneously. Hitting cancer with multiple mechanisms at the same time kills more cells and makes it much harder for any single cell to survive everything.

Good combinations follow guiding principles. Each drug should have proven activity against the cancer on its own, the drugs should work by different mechanisms, and ideally their major toxicities should not overlap, so the doses do not have to be cut. Drugs are usually given in cycles, with rest periods that let normal bone marrow and gut recover while the tumour, slower to recover, falls further behind. Classic regimens are named by abbreviations of their component drugs.

The main goals are higher response rates, longer remissions and reduced emergence of resistant cells, since a cell would need to resist all the drugs at once. The cost is greater combined toxicity and complexity. Modern regimens increasingly add targeted agents or immunotherapy to traditional cytotoxic backbones rather than relying on cytotoxics alone.